| Literature DB >> 35885934 |
Mohamed Salem1, Rafet Al-Tobasei2, Ali Ali1, Brett Kenney3.
Abstract
Rainbow trout, Oncorhynchus mykiss, is an important cool, freshwater aquaculture species used as a model for biological research. However, its genome reference has not been annotated for epigenetic markers affecting various biological processes, including muscle growth/atrophy. Increased energetic demands during gonadogenesis/reproduction provoke muscle atrophy in rainbow trout. We described DNA methylation and its associated gene expression in atrophying muscle by comparing gravid, diploid females to sterile, triploid females. Methyl Mini-seq and RNA-Seq were simultaneously used to characterize genome-wide DNA methylation and its association with gene expression in rainbow trout muscle. Genome-wide enrichment in the number of CpGs, accompanied by depleted methylation levels, was noticed around the gene transcription start site (TSS). Hypermethylation of CpG sites within ±1 kb on both sides of TSS (promoter and gene body) was weakly/moderately associated with reduced gene expression. Conversely, hypermethylation of the CpG sites in downstream regions of the gene body +2 to +10 kb was weakly associated with increased gene expression. Unlike mammalian genomes, rainbow trout gene promotors are poor in CpG islands, at <1% compared to 60%. No signs of genome-wide, differentially methylated (DM) CpGs were observed due to the polyploidy effect; only 1206 CpGs (0.03%) were differentially methylated, and these were primarily associated with muscle atrophy. Twenty-eight genes exhibited differential gene expression consistent with methylation levels of 31 DM CpGs. These 31 DM CpGs represent potential epigenetic markers of muscle atrophy in rainbow trout. The DM CpG-harboring genes are involved in apoptosis, epigenetic regulation, autophagy, collagen metabolism, cell membrane functions, and Homeobox proteins. Our study also identified genes explaining higher water content and modulated glycolysis previously shown as characteristic biochemical signs of rainbow trout muscle atrophy associated with sexual maturation. This study characterized DNA methylation in the rainbow trout genome and its correlation with gene expression. This work also identified novel epigenetic markers associated with muscle atrophy in fish/lower vertebrates.Entities:
Keywords: DNA methylation; epigenomics; gene expression; muscle; ploidy; rainbow trout
Mesh:
Year: 2022 PMID: 35885934 PMCID: PMC9319582 DOI: 10.3390/genes13071151
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.141
Figure 1Number of CpGs per nucleotide (left) and their average methylation percentage relative to TSS (right). The average percent of CpGs methylation flanking TSS was 57.7% within ±10 kb and 31.6% within ±2 kb, reaching as low as 12% near the TSS.
Figure 2Number of CpGs per nucleotide relative to TSS at different intervals of average methylation percentages.
Figure 3Inverse weak/moderate correlation between gene expression decile and DNA methylation within ±1 kb flanking TSS and positive correlation within the gene body’s +3 to +10 kb region.
Figure 4DNA methylation versus gene expression deciles. Inverse relationship between gene expression deciles (based on the increasing ranking of expression measured as RPKM) and gene methylation average percentages of CpGs within ±1 kb of TSS. The table shows the average gene methylation percentages and StdErr for each gene expression decile.
Figure 5Number of CpGs located in CGI per nucleotide (left) and their average methylation percentage relative to gene TSS (right).
Figure 6Inverse relationship between gene expression decile and DNA methylation in ±1 kb flanking TSS and positive correlation in +2 to +9 kb of the gene body.
Figure 7DNA methylation versus gene expression deciles. There is an inverse relationship between gene expression deciles (based on an increasing ranking of expression measured RPKM) and gene methylation average percentages of CGI within −2 kb and +2 kb of TSS. The table shows the average gene methylation percentages and StdErr for each gene expression decile.
Figure 8Density of CGIs in various genic regions and their relation to gene expression. Hypomethylation (0–44%) of CGIs was observed within 0 to +2 kb of TSS, regardless of gene expression level (top circle) and an increased percentage of the hypermethylated CGIs (>97%) in the highly expressed genes (right circle). Most CGIs at −2 to −10 upstream of genes are methylated (>44%), regardless of gene expression.
Figure 9Silenced genes (RPKM Decile 1) in rainbow trout muscle have more hypermethylated CGIs in the promoter region compared to the most highly expressed genes (Decile 10).
Gene ontology enrichment analysis of DM CpGs categorized in molecular functions (MF) and biological processes (BP).
| Source | Term_Name | Term_id | Adj_ |
|---|---|---|---|
| GO:MF | DNA-binding transcription factor activity, RNA polymerase II-specific | GO:0000981 | 1.96 × 10−3 |
| GO:MF | Metal ion transmembrane transporter activity | GO:0046873 | 2.24 × 10−2 |
| GO:BP | Homophilic cell adhesion via plasma membrane adhesion molecules | GO:0007156 | 6.60 × 10−5 |
| GO:BP | Cell adhesion | GO:0007155 | 3.18 × 10−2 |
| GO:BP | Biological adhesion | GO:0022610 | 3.18 × 10−2 |
| GO:BP | Cation transport | GO:0006812 | 1.66 × 10−2 |
| GO:BP | Metal ion transport | GO:0030001 | 9.59 × 10−3 |
| GO:BP | Cell-cell adhesion | GO:0098609 | 2.59 × 10−4 |
| GO:BP | Cell–cell adhesion via plasma-membrane adhesion molecules | GO:0098742 | 1.28 × 10−4 |
DM CpGs and their associated differential gene expression in atrophied muscle of gravid/2N fish compared to sterile/3N fish. Highlighted cells in green and red indicates positive and negative changes. Highlighted TFs are the most common transcription factors.
| Chr Position | Gene/Locus | Position to TSS | Hypo/Hyper Meth (2N–3N) | Meth. Diff | Exp. Fold Change (2N/3N) | Exp. FDR | Exp/Meth R Value | Gene Annotation | TF |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| NC_035082.1_64665435 | LOC110526468/Pdcd5 |
|
| 3.2 × 10−5 |
| 7.71 × 10−2 | −0.441 | Programmed cell death protein 5 | HES-1 [T01649]; RXR-alpha [T01345]; 3; MYB2 [T02536]; AR [T00040]; USF-1 [T00875]; NF-1 [T00537]; NF-1 [T00539] |
| NC_035082.1_64665694 | LOC110526468/Pdcd6 |
|
| 3.2 × 10−5 |
| 7.71 × 10−2 | −0.497 | Programmed cell death protein 5 | c-Ets-1 [T00112] |
| NC_035078.1_41106515 | LOC110492018/AEN |
|
| 7.5 × 10−6 |
| 1.01 × 10−4 | 0.434 | Apoptosis-enhancing nuclease | E2F-1 [T01542]; C/EBPbeta [T00581]; C/EBPgamma [T00216]; NF-1 [T00535] |
| NC_035081.1_29419783 | LOC110523624/Smyd1 |
|
| 4.0 × 10−7 |
| 6.10 × 10−3 | 0.459 | Histone-lysine N-methyl transferase Smyd1 | LyF-1 [T00479]; PTF1-beta [T00701]; |
| NC_035088.1_13620476 | LOC110537077/Cdk2ap1 |
|
| 1.7 × 10−5 |
| 9.39 × 10−5 | −0.439 | Cyclin-dependent kinase 2-associated protein 1 | USF1 [T00874]; USF1 [T00874]; c-Myc [T00140]; RXR-beta [T01349]; RXR-beta [T01349]; PIF3 [T04492]; PIF3 [T04492]; SREBP-1c [T01562]; CBF1 [T00080]; CBF1 [T00080]; JunD [T00437]; JunD [T00437] |
| NC_035089.1_41352275 | LOC110486510/Ddx39a |
|
| 9.9 × 10−6 |
| 5.57 × 10−2 | 0.625 | ATP-dependent RNA helicase DDX39A | XBP-1 [T00902]; E2F-1 [T01542]; f(alpha)-f(epsilon) [T00287] |
| NC_035089.1_41352276 | LOC110486510/Ddx39a |
|
| 5.2 × 10−6 |
| 5.57 × 10−2 | 0.264 | ATP-dependent RNA helicase DDX39A | XBP-1 [T00902]; E2F-1 [T01542]; f(alpha)-f(epsilon) [T00287] |
|
| |||||||||
| NC_035082.1_53102690 | LOC110526208/Atg13 |
|
| 1.3 × 10−5 |
| 7.86 × 10−2 | −0.674 | Autophagy-related protein 13 | |
| NC_035101.1_26128247 | LOC110504991/Sesn3 |
|
| 3.4 × 10−5 |
| 1.25 × 10−2 | 0.820 | Sestrin-3 | GAGA factor [T00301] |
| NC_035093.1_46301679 | LOC110494292/Pfkfb3 |
|
| 6.7 × 10−16 |
| 2.86 × 10−3 | 0.725 | 6-phosphofructo-2-kinase | MCB1 [T06035]; MCB2 [T06036]; |
| NC_035094.1_5494483 | LOC110495489/Col8a1 |
|
| 3.5 × 10−5 |
| 1.30 × 10−4 | 0.686 | Collagen alpha-1(VIII) chain | NF-E4 [T00560]; Sp1 [T00754]; Sp1 [T00759] |
| NC_035088.1_66751403/island11919 | LOC110538176/P3h4 |
|
| 7.1 × 10−7 |
| 7.35 × 10−2 | 0.283 | Prolyl 3-hydroxylase family member 4 (non-enzymatic) | USF1 [T00874]; USF1 [T00874]; c-Myc [T00140]; PHO4 [T00690]; USF-1 [T00875]; USF-1 [T00875]; HES-1 [T01649]; HES-1 [T01649] |
| NC_035082.1_40371257 | LOC110526004/Prodhb |
|
| 6.4 × 10−6 |
| 1.73 × 10−2 | 0.594 | Proline dehydrogenase 1, mitochondrial | |
| NC_035088.1_41298016 | LOC110537666/Gdpd5 |
|
| 1.2 × 10−5 |
| 3.30 × 10−6 | 0.139 | Glycerophosphodiester phosphodiesterase domain-containing protein 5 | |
| NC_035093.1_33080772 | LOC110494010/Aqp7 |
|
| 9.4 × 10−6 |
| 2.32 × 10−3 | 0.358 | Aquaporin-7 | SXR:RXR-alpha [T05670]; HES-1 [T01649] |
| NC_035105.1_28018844/island23784 | LOC110509954/Tmem151b |
|
| 3.3 × 10−5 |
| 1.65 × 10−3 | 0.639 | Transmembrane protein 151B | |
| NC_035087.1_56212451 | LOC110536085/Ank1 |
|
| 1.2 × 10−5 |
| 6.32 × 10−2 | 0.079 | Ankyrin-1 | NFI/CTF [T00094]; NF-AT2 [T01945]; PEA3 [T00684]; NF-AT1 [T01948]; NF-AT1 [T01944];NF-AT1 [T00550]; HNF-4alpha1 [T00372] |
|
| |||||||||
| NC_035092.1_38302815 | LOC110492001/Hox-C5a |
|
| 7.8 × 10−6 |
| 1.48 × 10−2 | 0.474 | Homeobox protein Hox-C5a | c-Myb [T00138] |
| NC_035092.1_38302823 | LOC110492001/Hox-C5a |
|
| 2.6 × 10−5 |
| 1.48 × 10−2 | 0.382 | Homeobox protein Hox-C5a | Sp1 [T00755]; Nkx2-1 [T00857] |
| NC_035101.1_61368566 | Six4 |
|
| 3.6 × 10−5 |
| 6.73 × 10−2 | 0.015 | SIX homeobox 4 | MF3 [T00507]; ENKTF-1 [T00255]; Tll [T00789]; E2F [T00221]; POU4F1(l) [T01877]; |
|
| |||||||||
| NC_035084.1_10667325 | Hsp90ba |
|
| 8.6 × 10−7 |
| 9.16 × 10−2 | 0.698 | Heat shock 90kDa protein 1 beta isoform a | TAF [T00778] |
| NC_035091.1_7350831 | LOC110489569/Ccts |
|
| 3.7 × 10−6 |
| 8.21 × 10−4 | 0.297 | T-complex protein 1 subunit epsilon | Mad [T04378]; LF-A1 [T00467]; MF3 [T00507]; E2F-1 [T01543]; YY1 [T00865]; XBP-1 [T00902]; YY1 [T00915]; Sp1 [T00754]; Sp1 [T00759]; YY1 [T00278]; ENKTF-1 [T00255] |
| NC_035084.1_34778859 | LOC110529890/PGBD4 |
|
| 1.9 × 10−6 |
| 8.85 × 10−6 | −0.505 | PiggyBac transposable element-derived protein 4 | HNF-1B [T01950]; Crx [T03461]; POU2F1 [T00643] |
| NC_035077.1_13381573 | LOC110493215/Mast3 |
|
| 1.2 × 10−5 |
| 9.8 × 10−2 | −0.119 | Microtubule-associated serine/threonine-protein kinase 3 | C/EBP [T01388]; CREMtau [T01309]; CREMtaualpha [T01602]; CREMtau1 [T02108]; CREMtau2 [T02109] |
| NC_035092.1_36914362 | LOC110491948/Cacna1sb |
|
| 2.0 × 10−6 |
| 2.96 × 10−6 | 0.858 | Dihydropyridine-sensitive L-type skeletal muscle calcium channel subunit alpha-1 | MED8 [T03491]; C/EBP [T01388]; C/EBP [T01388] |
| NC_035092.1_29706361 | LOC110491830/Cytc-1 |
|
| 3.3 × 10−5 |
| 1.46 × 10−4 | 0.123 | Cytochrome c1 | Mad [T04378]; GA-BF [T00297] |
| NC_035090.1_23141191 | LOC110488198/Cpsf1 |
|
| 2.1 × 10−7 |
| 1.34 × 10−2 | 0.406 | Cleavage and polyadenylation specificity factor subunit 1 | |
| NC_035093.1_25737498 | LOC110493184/Znfx-1 |
|
| 4.8 × 10−5 |
| 7.87 × 10−2 | 0.324 | NFX1-type zinc finger-containing protein 1 | |
| NC_035097.1_35527983 | LOC110500515/Gilgyf1 |
|
| 1.7 × 10−5 |
| 7.18 × 10−2 | 0.772 | GRB10-interacting GYF protein 1 | Mad [T04378]; |
| NC_035095.1_15029930 | LOC110497457 |
|
| 2.0 × 10−5 |
| 8.65 × 10−3 | 0.637 | Vegetative cell wall protein gp1 | |
| NC_035097.1_10910032 | LOC110501017 |
|
| 5.3 × 10−8 |
| 2.37 × 10−2 | −0.417 | Uncharacterized LOC110501017 | HSF1 (long) [T01042]; HSF1 (short) [T02104]; AP-4 [T00036]; |